Skip to main content
PYXS
NASDAQ Life Sciences

Pyxis Oncology's MICVO Shows 36% ORR and 94% DCR in Updated Phase 1 HNSCC Data

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$4.14
Mkt Cap
$324.457M
52W Low
$1.03
52W High
$5.55
52W Position info
302% above low
Off High info
25% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

PYXS has more than doubled off its 52-week low of $1.03.

Summary

Pyxis Oncology reported updated Phase 1 data for MICVO in 2L+ R/M HNSCC, showing a 36% confirmed objective response rate and 94% disease control rate in 33 efficacy-evaluable patients. Median progression-free survival was 6.2 months and 12-month overall survival probability was 79%, with no new safety signals. The company plans to initiate a Phase 3 Headliner trial in mid-2027 following an End of Phase 2 meeting with the FDA in Q1 2027. This follows the Q2 2026 update and the recent appointment of Thomas Civik as permanent CEO. The data support advancement to a pivotal program and could significantly de-risk the lead asset.

At the time of this announcement, PYXS was trading at $4.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $324.5M. The 52-week trading range was $1.03 to $5.55. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PYXS - Latest Insights

PYXS
Nov 19, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.50
Real-time Price: $1.80 info
Change: +$0.300 (+20%) info
Market Cap: $215.294M info
PYXS
Nov 18, 2026, 6:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.46
Real-time Price: $1.80 info
Change: +$0.340 (+23%) info
Market Cap: $215.294M info
PYXS
Nov 13, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.80 info
Change: +$0.220 (+14%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info
PYXS
Nov 05, 2026, 7:39 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.80 info
Change: +$0.150 (+9%) info
Market Cap: $215.294M info